G340(P) Ethosuximide Retention in Children with Epilepsy
G340(P) Ethosuximide Retention in Children with Epilepsy
About this item
Full title
Author / Creator
Pickerd, N , Gale, K , Hartley, L , Gibbon, F and te WaterNaude, J
Publisher
London: BMJ Publishing Group LTD
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group LTD
Subjects
More information
Scope and Contents
Contents
Ethosuximide is recommended as first line treatment for childhood absence epilepsy (CAE)1. It has been found to be more effective than Lamotrigine and to have fewer side effects than Lamotrigine and Valproate2. Objective The aim of this study was to assess the efficacy and tolerability of Ethosuximide in children. Methods The notes of all patients...
Alternative Titles
Full title
G340(P) Ethosuximide Retention in Children with Epilepsy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1828888512
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1828888512
Other Identifiers
ISSN
0003-9888
E-ISSN
1468-2044
DOI
10.1136/archdischild-2014-306237.323
